BSE Live
Nov 14, 16:01Prev. Close
167.25
Open Price
168.65
Bid Price (Qty.)
161.90 (170)
Offer Price (Qty.)
163.00 (50)
NSE Live
Nov 14, 15:58Prev. Close
167.43
Open Price
168.45
Bid Price (Qty.)
161.75 (122938)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Bliss GVS Pharma (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 91.25 | 82.30 | 104.83 | 79.71 | 52.98 | |
| Net CashFlow From Operating Activities | 3.43 | 54.92 | -51.86 | 78.03 | 23.66 | |
| Net Cash Used In Investing Activities | -25.25 | -8.96 | -26.80 | -24.24 | -9.79 | |
| Net Cash Used From Financing Activities | -15.16 | -2.65 | 51.56 | -13.86 | -11.20 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -36.98 | 43.31 | -27.09 | 39.92 | 2.66 | |
| Cash And Cash Equivalents Begin of Year | 43.32 | 30.82 | 57.90 | 17.98 | 15.32 | |
| Cash And Cash Equivalents End Of Year | 6.34 | 74.12 | 30.82 | 57.90 | 17.98 |
07.11.2025
Bliss GVS Consolidated September 2025 Net Sales at Rs 244.40 crore, up 12.27% Y-o-Y
30.07.2025
Bliss GVS Consolidated June 2025 Net Sales at Rs 207.47 crore, up 12.97% Y-o-Y
30.07.2025
Bliss GVS Standalone June 2025 Net Sales at Rs 163.36 crore, up 9.67% Y-o-Y
13.05.2025
Bliss GVS Standalone March 2025 Net Sales at Rs 156.00 crore, down 4.77% Y-o-Y